COMMUNIQUÉS West-GlobeNewswire

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/06/2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in [...]
Fennec Announces Results of Annual Meeting
03/06/2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
03/06/2025
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company. Attachments Notification of managers' [...]
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
03/06/2025
Recently disclosed clinical cohort data from high (1x10 15 total vg) and low dose (5.7x10 14 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of [...]
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
03/06/2025
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today the pricing and early acceptance results of its previously announced tender offers [...]
EssilorLuxottica : Succès du placement d'une émission obligataire d’un montant d’1 milliard d'euros
03/06/2025
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D’AMÉRIQUE, AU CANADA, EN AUSTRALIE, AU JAPON, EN AFRIQUE DU SUD OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE IL SERAIT ILLÉGAL DE LE [...]
EssilorLuxottica: successful Euro 1 billion bond issuance
03/06/2025
NOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR [...]
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
03/06/2025
Biofrontera received patent approval for the revised formulation of Ameluz ® in April 2025, extending patent protection through to December 2043. The Orange Book is published by the U.S. Food and Drug Administration ( [...]
Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
03/06/2025
Immix Biopharma today presented results at ASCO from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201, meeting its primary endpoint. – NXC-201 met primary endpoint with a complete response (CR) rate [...]
Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045
03/06/2025
LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced it [...]
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes
03/06/2025
Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a [...]
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
03/06/2025
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a clinical-stage [...]
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
03/06/2025
ATLANTA, June 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related [...]
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Evaxion receives grant funding to design new polio vaccine
03/06/2025
Evaxion awarded a grant from the Gates Foundation Grant funds research aimed at ultimately eradicating polio, a highly infectious viral disease Evaxion will apply its leading AI-Immunology™ platform to identify and [...]
EssilorLuxottica: Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante
03/06/2025
Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante Paris, France (3 juin 2025 - 16h30) – L’Assemblée générale annuelle d’EssilorLuxottica a décidé de donner aux [...]
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
03/06/2025
Result of the payment of dividends in shares and record of the corresponding capital increase Paris, France (June 3, 2025 – 4:30 pm) – The Annual General Meeting of EssilorLuxottica has decided to grant to the [...]
Epilepsy Foundation of America Awards $250,000 at 13th Annual Shark Tank Competition
03/06/2025
Janine Erler, winner of the 2025 Investment Prize for Neumirna Therapeutics. Presenting the prize is Bernice Martin Lee, Epilepsy Foundation of America’s (EFA) Chief Executive Officer; Jacqueline French, MD, EFA’s [...]

Pages